Clinical Trial Update: Serplulimab Combined With Chemotherapy for Early-stage HR+/HER2- Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating serplulimab in combination with chemotherapy for early-stage HR+/HER2- breast cancer, and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Serplulimab (serplulimab)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: HR+/HER2- Breast Cancer | Phase 2 | Status: RECRUITING